SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001551163-15-000010
Filing Date
2015-02-12
Accepted
2015-02-11 18:39:39
Documents
10
Period of Report
2014-12-31

Document Format Files

Seq Description Document Type Size
1 sangui_dec201410qedgarv3.htm 10-Q 419765
2 exhibit3101vedgar1.htm EX-31 10596
3 exhibit3102vedgar1.htm EX-31 10754
4 exhibit3201vedgar1.htm EX-32 9025
  Complete submission text file 0001551163-15-000010.txt   1309830

Data Files

Seq Description Document Type Size
5 sgbi-20141231.xml EX-101.INS 57265
6 sgbi-20141231.xsd EX-101.SCH 13773
7 sgbi-20141231_cal.xml EX-101.CAL 13925
8 sgbi-20141231_def.xml EX-101.DEF 10302
9 sgbi-20141231_lab.xml EX-101.LAB 77815
10 sgbi-20141231_pre.xml EX-101.PRE 65794
Mailing Address 291 SOUTH 200 WEST P.O. BOX 832 FARMINGTON UT 84025
Business Address 291 SOUTH 200 WEST P.O. BOX 832 FARMINGTON UT 84025 011 49 1607 412717
SANGUI BIOTECH INTERNATIONAL INC (Filer) CIK: 0001104280 (see all company filings)

IRS No.: 841330732 | State of Incorp.: CO | Fiscal Year End: 0630
Type: 10-Q | Act: 34 | File No.: 000-29233 | Film No.: 15601096
SIC: 2834 Pharmaceutical Preparations